AbbVie (ABBV) Minority Interest (2020 - 2026)

AbbVie has disclosed Minority Interest across 7 years of filings, most recently posting $44.0 million for Q1 2026.

• In Q1 2026, Minority Interest rose 4.76% year-over-year to $44.0 million; the TTM figure through Mar 2026 stood at $44.0 million (up 4.76% YoY), while the FY2025 annual figure was $42.0 million, up 7.69% from the prior year.
• Minority Interest advanced to $44.0 million in Q1 2026, from $42.0 million in the prior quarter.
• Over the last five years, Minority Interest for ABBV reached as high as $45.0 million in Q2 2025 and fell as low as $29.0 million in Q1 2023.
• The 5-year median for Minority Interest is $39.0 million (2024), against an average of $37.8 million.
• Annual changes were most pronounced in 2022 — Minority Interest soared 40.0% — and 2023, when it slipped 8.57%.
• A 5-year view of Minority Interest shows it stood at $33.0 million in 2022, then climbed by 12.12% to $37.0 million in 2023, then increased by 5.41% to $39.0 million in 2024, then increased by 7.69% to $42.0 million in 2025, then increased by 4.76% to $44.0 million in 2026.
• According to Business Quant data, Minority Interest over the past three periods registered $44.0 million, $42.0 million, and $43.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.